FDA's electronic signatures/records rule benefits outweigh costs, agency says.
This article was originally published in The Tan Sheet
Executive Summary
ELECTRONIC SIGNATURES/RECORDS FINAL RULE COSTS OFFSET BY BENEFITS "to be realized by using trustworthy and reliable electronic records and electronic signatures," FDA tells the Pharmaceutical Research & Manufacturers of America in a March 9 response to association comments on the rule. The benefits include "decreased time to prepare premarket approval applications, decreased data storage costs, decreased FDA review time [and] improved operational efficiencies," FDA says.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning